These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 39259061)
1. Construction and validation of a necroptosis-related prognostic signature in acute myeloid leukemia. Pan YQ; Yang K; Zhang X; Li YX; Guo C; Chen ZH; Du Y Medicine (Baltimore); 2024 May; 103(22):e38432. PubMed ID: 39259061 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia. Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258 [TBL] [Abstract][Full Text] [Related]
3. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma. Xu L; Gao X; Xing J; Guo Z Front Immunol; 2023; 14():1118816. PubMed ID: 36936916 [TBL] [Abstract][Full Text] [Related]
4. A novel necroptosis signature for predicting survival in lung adenocarcinoma. Zang K; Wang M; Zhu X; Yao B; Huang Y BMC Med Genomics; 2023 Nov; 16(1):305. PubMed ID: 38017445 [TBL] [Abstract][Full Text] [Related]
5. A Novel Identified Necroptosis-Related Risk Signature for Prognosis Prediction and Immune Infiltration Indication in Acute Myeloid Leukemia Patients. Sun Y; Wang R; Xie S; Wang Y; Liu H Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292722 [TBL] [Abstract][Full Text] [Related]
6. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. Sun K; Huang C; Li JZ; Luo ZX World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777 [TBL] [Abstract][Full Text] [Related]
7. A Novel Defined Necroptosis-Related Genes Prognostic Signature for Predicting Prognosis and Treatment of Osteosarcoma. Zhao S; Wang T; Huang F; Zhao Q; Gong D; Liu J; Yi C; Liang S; Bian E; Tian D; Jing J Biochem Genet; 2024 Apr; 62(2):831-852. PubMed ID: 37460861 [TBL] [Abstract][Full Text] [Related]
8. Identification of necroptosis-related gene signature and characterization of tumour microenvironment infiltration in non-small-cell lung cancer. Dai J; Fu Y J Cell Mol Med; 2022 Sep; 26(17):4698-4709. PubMed ID: 35871768 [TBL] [Abstract][Full Text] [Related]
9. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma. Yang B; Wang Y; Liu T; Zhang M; Luo T Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403 [TBL] [Abstract][Full Text] [Related]
10. Identification of a signature based on non-apoptotic regulatory cell death to improve prognosis prediction in acute myeloid leukaemia. Zheng Y; Weng X; Hu D; He J Br J Haematol; 2023 Apr; 201(1):95-105. PubMed ID: 36484284 [TBL] [Abstract][Full Text] [Related]
11. Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma. Tao Q; Lang Z; Li Y; Gao Y; Lin L; Yu Z; Zheng J; Yu S BMC Cancer; 2023 Oct; 23(1):1029. PubMed ID: 37875823 [TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a SASP-related prognostic signature in patients with acute myeloid leukaemia. Li MF; Zhang DH; Wang LS; Yue CF; Pang LJ; Guo YM; Yang ZG J Cell Mol Med; 2024 Aug; 28(16):e70017. PubMed ID: 39159071 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma. Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers. Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839 [TBL] [Abstract][Full Text] [Related]
15. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia. Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858 [TBL] [Abstract][Full Text] [Related]
16. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma. Peng YL; Wang LX; Li MY; Liu LP; Li RS PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724 [TBL] [Abstract][Full Text] [Related]
17. A novel necroptosis-related gene signature in acute myeloid leukemia. Fang W; Lin H; Chen J; Guo W Hematology; 2023 Dec; 28(1):2227491. PubMed ID: 37367830 [TBL] [Abstract][Full Text] [Related]
18. NET-related gene signature for predicting AML prognosis. Wang J; Wang H; Ding Y; Jiao X; Zhu J; Zhai Z Sci Rep; 2024 Apr; 14(1):9115. PubMed ID: 38643300 [TBL] [Abstract][Full Text] [Related]
19. NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia. Cao Y; Shu W; Jin P; Li J; Zhu H; Chen X; Zhu Y; Huang X; Cheng W; Shen Y Front Immunol; 2024; 15():1417398. PubMed ID: 38966636 [TBL] [Abstract][Full Text] [Related]
20. Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes. Li Z; Yang W; Liu D; Ye W; Du G; Li X Sci Rep; 2022 Aug; 12(1):13290. PubMed ID: 35918354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]